<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present an overview of the treatment and clinical outcome of 15 orbital <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, carried out in our center from 1993 to 2002 </plain></SENT>
<SENT sid="1" pm="."><plain>The surgical approach was determined by the location, and type of the lesion </plain></SENT>
<SENT sid="2" pm="."><plain>Lateral orbitotomy was performed in five laterally located lesions, a transconjunctival approach in five medial, basal, extra-, intraconal lesions </plain></SENT>
<SENT sid="3" pm="."><plain>Pterional intradural and extradural and intradural approaches (three) were used in case of intracranial involvement or location in the apex and optic canal </plain></SENT>
<SENT sid="4" pm="."><plain>Two lesions of the lid or extraconal space were operated via eyebrow incision </plain></SENT>
<SENT sid="5" pm="."><plain>Ten patients were diagnosed as extranodal marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (DLCL) was encountered in two patients, follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FCL) in two patients, and diffuse lymphoplasmacytic/lymphoplasmacytoid <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in one patient </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients except one failed to reveal <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic disease</z:e> and had a localized orbital <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Twelve of the patients responded to radiation therapy with usually 40 Gy </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi>, <z:chebi fb="0" ids="28748">doxorubicin</z:chebi>, <z:chebi fb="0" ids="28445">vincristine</z:chebi>, <z:chebi fb="0" ids="8382">prednisone</z:chebi> chemotherapy was applied in two patients, once in combination with radiotherapy </plain></SENT>
<SENT sid="10" pm="."><plain>Local recurrence was seen in one patient with FCL </plain></SENT>
<SENT sid="11" pm="."><plain>Systemic manifestation occurred in one patient with DLCL, undergoing ifosfamide, <z:chebi fb="2" ids="31355">carboplatin</z:chebi>, <z:chebi fb="0" ids="4911">etoposide</z:chebi> chemotherapy with complete remission </plain></SENT>
<SENT sid="12" pm="."><plain>The course of orbital non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is variable and requires a multidisciplinary treatment </plain></SENT>
<SENT sid="13" pm="."><plain>Therapeutic options include surgical biopsy, radiation therapy, and chemotherapy </plain></SENT>
</text></document>